Global Obesity Management Market Overview
Sedentary lifestyle, and overeating are often linked with obesity. Obesity is now a global issue as it is prevalent in high, middle and low-income countries. Prevalence of obesity has increased significantly in recent years and thereby driving the demand for its treatment and management. The global obesity management market is expected to exhibit a compound annual growth rate (CAGR) of 8.4% during 2015-2022 finds Market Research Future (MRFR) in its latest study. In addition, the market is expected to surpass a valuation of USD 6 Bn towards the end of forecast period.
Free Sample PDF Available Here!! https://www.marketresearchfuture.com/sample_request/2690
Obesity is a highly complex disorder and requires rigorous monitoring. Moreover, there is severe scepticism over obesity treatment options and medications owing to risk of side-effects and outcomes. This is promoting pharmaceutical companies to focus on R&D pipelines. Obesity is often cited as catalyst for development of others chronic diseases such as heart diseases, hypertension, diabetes, among others. Nevertheless, advances in healthcare technology, helped in developing more effective and safer obesity management solutions.
Obesity Management Market Top Key Players
Some of the prominent companies operating in the global obesity management market include
- Merck Sharp & Dohme Corp
- Pfizer Inc
- Ethicon
- AstraZeneca
- Apollo Endosurgery
- Herbalife
- Hoffmann-La Roche Ltd (Switzerland)
- GlaxoSmithKline
Obesity Management Market Segmental Overview
The segmental analysis of the global obesity management market has been conducted on the basis of prescription, surgery and lifestyle changes.
Based on prescription, the market has been segmented into lorcaserin (Belviq), buproprion and naltrexone (Contrave), liraglutide (Saxenda), orlistat (Xenical), phentermine and topiramate (Qsymia) and others. Based on surgery, the market has been segmented into Biliopancreatic diversion with duodenal switch, Laparoscopic adjustable gastric banding (LAGB), Gastric bypass surgery and others. Based on lifestyle changes, the market has been segmented into exercise, dietary changes and others.
Global Obesity Management Market: Regional Segmentation
Key regions discussed in the MRFR’s report include Americas, Asia Pacific (APAC), and Europe. North America dominates the global obesity management market. High healthcare expenditure and a readily accessible healthcare support systems are among the key factors supporting the market growth in North America. A significant number of Americans are affected by obesity and its associated disorders. Europe ranks second in the pecking order. Well established healthcare system and high awareness level are propelling the market in Europe. The market growth in Asia-Pacific is also expected to be impressive during the forecast period. The region displays significant market potential; increased focus on improving healthcare services, awareness campaigns initiated by governments and improved healthcare penetration indicates towards a favourable climate for market players operating in the region. Countries such as China, Taiwan, India, Japan, South Korea are registering a higher number of over-nourishment cases. Increasing disposable income, and lifestyle changes are factors that can be associated with rise in prevalence of obesity. Favourable policies, faster adoption of advanced healthcare technologies, expanding R&D investment corpus is providing an impetus. Growing per capita income in countries such as China and India along with the expanding patient pool make them attractive investment destinations.
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690
Industry News Updates
The World Obesity Federation is reportedly launching an innovative patient network, which will cater to obesity patients. The network is being backed by clinicians across Lebanon and the Gulf. It is designed to drive awareness about the causes of obesity and give suggestion of healthier lifestyle choices, management programs and treatment options.
Leading pharmaceutical company Boehringer Ingelheim has recently partnered with Government of Alberta, Canada, and the University Hospital Foundation to develop and provide effective solutions for COPD patients. The partnership will be focused on narrowing the gaps in COPD and its associated disorders including obesity, heart failure, and diabetes.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
